Terakedis Breanne E, Hunt Jason P, Buchmann Luke O, Avizonis Vilija N, Anker Christopher J, Hitchcock Ying J
Departments of *Radiation Oncology †Otolaryngology-Head and Neck Surgery, University of Utah Huntsman Cancer Hospital, Salt Lake City ‡Department of Radiation Oncology, Intermountain Medical Center, Murray, UT §Department of Radiation Oncology, University of Vermont, Burlington, VT.
Am J Clin Oncol. 2017 Jun;40(3):323-328. doi: 10.1097/COC.0000000000000157.
Facial nerve (FN) palsy and perineural invasion (PNI) are adverse features in carcinomas of the parotid gland. FN sacrifice at the time of surgery is associated with significant morbidity. The role of adjuvant radiotherapy in patients with high-risk features, including FN involvement, remains unclear.
Analyze the disease-free survival (DFS) and overall survival (OS) and the impact of tumor characteristics, including FN involvement, for patients treated with surgical resection for carcinoma of the parotid gland.
This is a retrospective chart review.
University of Utah and Intermountain Healthcare, Utah.
A total of 129 patients who were treated with primary surgery for nonmetastatic primary malignancies of the parotid gland from 1988 to 2006.
Parotidectomy with or without adjuvant therapy.
MAIN OUTCOME(S) AND MEASURES: Kaplan-Meier analysis was used to obtain 5-year estimates of DFS and OS. Recurrence risk factors, particularly the impact of FN involvement, were analyzed.
Five-year DFS and OS rates were 79% and 78%, respectively. Thirty-two (28%) patients developed recurrent disease. Disease recurrence occurred in 64% of patients with both FN palsy and PNI, in 43% with FN palsy without PNI, in 27% with only PNI, and in 16% without either feature.
FN involvement, particularly FN palsy, is a predictor of increased risk of recurrence and death. Radiotherapy cannot substitute for FN sacrifice in high-risk patients.
面神经(FN)麻痹和神经周围侵犯(PNI)是腮腺癌的不良特征。手术时切除面神经会带来显著的发病率。辅助放疗在包括面神经受累在内的高危特征患者中的作用仍不明确。
分析接受腮腺癌手术切除患者的无病生存期(DFS)和总生存期(OS),以及包括面神经受累在内的肿瘤特征的影响。
这是一项回顾性病历审查。
犹他大学和犹他州山间医疗保健机构。
1988年至2006年期间共129例接受腮腺非转移性原发性恶性肿瘤初次手术治疗的患者。
腮腺切除术,伴或不伴辅助治疗。
采用Kaplan-Meier分析得出DFS和OS的5年估计值。分析复发危险因素,尤其是面神经受累的影响。
5年DFS率和OS率分别为79%和78%。32例(28%)患者出现疾病复发。面神经麻痹且伴有PNI的患者中64%出现疾病复发,仅面神经麻痹而无PNI的患者中43%复发,仅PNI的患者中27%复发,无任何一种特征的患者中16%复发。
面神经受累,尤其是面神经麻痹,是复发和死亡风险增加的预测因素。放疗不能替代高危患者的面神经切除。